In vitro production of anti-RBC antibodies and cytokines in chronic lymphocytic leukemia
Open Access
- 30 October 2002
- journal article
- research article
- Published by Wiley in American Journal of Hematology
- Vol. 71 (3) , 177-183
- https://doi.org/10.1002/ajh.10210
Abstract
No abstract availableKeywords
This publication has 30 references indexed in Scilit:
- Reduced IL-4 and interferon-gamma (IFN-γ) expression by CD4 T cells in patients with chronic lymphocytic leukaemiaClinical and Experimental Immunology, 1999
- IL4 production and increased CD30 expression by a unique CD8+ T‐cell subset in B‐cell chronic lymphocytic leukaemiaBritish Journal of Haematology, 1999
- Diminished production of interleukin‐6 in chronic lymphocytic leukaemia (B‐CLL) cells from patients at advanced stages of diseaseBritish Journal of Haematology, 1998
- Altered pattern of cytokine production by peripheral blood CD2+ cells from B chronic lymphocytic leukemia patientsAmerican Journal of Hematology, 1998
- Interleukin-10 Inhibits theIn vitroProliferation of Human Activated Leukemic CD5+B-CellsLeukemia & Lymphoma, 1998
- TGF-β Activity and Expression of its Receptors in B-Cell Chronic Lymphocytic LeukemiaLeukemia & Lymphoma, 1998
- Interleukin 10 induces apoptotic cell death of B-chronic lymphocytic leukemia cells.The Journal of Experimental Medicine, 1994
- Interferon gamma inhibits apoptotic cell death in B cell chronic lymphocytic leukemia.The Journal of Experimental Medicine, 1993
- Interleukin 4 protects chronic lymphocytic leukemic B cells from death by apoptosis and upregulates Bcl-2 expression.The Journal of Experimental Medicine, 1992
- TUMOUR NECROSIS FACTOR AS AN AUTOCRINE TUMOUR GROWTH FACTOR FOR CHRONIC B-CELL MALIGNANCIESThe Lancet, 1988